Our goal is to reverse the human aging process and cure diseases linked to aging by activating telomerase and thus extending telomeres, leading the cells to return to a state of youthful gene expression and function.
Defytime is a corporate group and a brand. Our operation is headquartered in Auckland New Zealand, with labs co-located in The University of Auckland and research and development with Sierra Sciences, LLC, in Reno, Nevada USA. Our first anti-aging clinic is located in Vanuatu.
The strongest telomerase inducer identified so far from the research of Bill Andrews, Ph.D. and Sierra Sciences is CO314818. We have done additional medicinal chemistry with the compound to develop TAM, which we combine with proven ingredients to create our range of beauty and aging care products.
Part of the proceeds of our sales go toward furthering Dr. Bill Andrews’ telomere research.
Defytime Operations HQ in Auckland New Zealand
Sierra Sciences, LLC
Sierra Sciences, LLC, is a biotech company, with the goal of preventing and/or reversing cellular senescence, and ultimately curing diseases associated with human aging, including the aging process itself.
This cutting edge research is led by Bill Andrews, Ph.D, Founder and CEO of Sierra Sciences. Dr. Andrews has worked in the biotech industry for over 35 years, focusing the last 20 years on finding ways to extend human lifespan through the intervention of telomere shortening in human cells.
Their lab is located in the middle of Northern Nevada’s technology district. With over 10,000 square feet, their lab is a prominent state-of-the-art research center in the area.
Dr. Bill Andrews in the lab at Sierra Sciences, Reno, Nevada USA
Bill Andrews, Ph.D.
President & CEO
As a scientist, athlete and executive, Bill Andrews, Ph.D. continually pushes the envelope and challenges convention. He has been featured in Popular Science, The Today Show and numerous documentaries on the topic of life extension including, most recently, the movie The Immortalists in which he co-stars with Aubrey de Grey.
Dr. Andrews earned his Ph.D. in Molecular and Population Genetics at the University of Georgia in 1981. He was a Senior Scientist at Armos Corporation and Codon Corporation, Director of Molecular Biology at Codon and at Geron Corporation, and Director of Technology Development at EOS Biosciences.
While Director of Molecular Biology at Geron Corporation from 1992 to 1997, Bill Andrews, Ph.D. was one of the principal discoverers of both the RNA and protein components of human telomerase and was awarded 2nd place as “National Inventor of the Year” in 1997 for this work. He is also a named inventor on over 50+ US issued patents on telomerase and author of numerous scientific research studies published in peer reviewed scientific journals.
Laura A. Briggs, Ph.D.
Vice President of Research & Discovery
Laura Briggs received her B.S. degree in Nutrition in 1993 and her Ph.D. in Environmental Science and Health in 2000 from the University of Nevada, Reno. After a one-year post-doctoral position at UNR she joined Sierra Sciences in 2001. In addition to coordinating research and development at Sierra Sciences, Dr. Briggs is also currently serving as the biology Lab Coordinator for Truckee Meadows Community College (TMCC) and has collaborated on research projects at the V.A. Medical Center in Reno, Nevada.
Director of Business Development
Jonathan Greenwood is Director of Business Development and CEO of Defytime Holdings Ltd. After graduating from Architecture University, he became an entrepreneur between Antipodean and East Asia. In his 15 years global marketing sales experience, he built excellent clients from the Asian markets and a large network in the Southeast Asia market. His management skills and understanding of the region adds tremendous value in making Defytime and Sierra Sciences a world class anti-aging destination.
Lancer Brown, M.S.
Program Director of Screening
Lancer Brown received his B.S. and M.S. degrees in Biotechnology in 2003 from the University of Nevada, Reno and was one of three students in the inaugural advanced BS/MS Biotechnology Program. He distinguished himself by being the first student to complete the program. Lancer came to Sierra Sciences as an intern while completing his degree. Following graduation, he joined Sierra Sciences full-time where he has proven to have remarkable ability to engineer genes and DNA.
Federico Gaeta, Ph.D.
Dr. Gaeta identified the first potent, small molecule, inhibitors of human telomerase. He is the sole inventor of universal therapeutic cancer vaccine technologies based on telomerase, currently being evaluated in human clinical trials. Dr. Gaeta is an experienced executive with major pharmaceutical and biotechnology companies in the area of new drug discovery and development.